passive immunotherapy
Showing 1 - 25 of 4,515
COVID-19 Trial in Vigo (Convalescent plasma)
Completed
- COVID-19
- Convalescent plasma
-
Vigo, SpainHospital Álvaro Cunqueiro
Oct 5, 2022
COVID-19 Pneumonia, COVID-19 Respiratory Infection, Covid19 Trial in Ciudad Autónoma De Buenos Aires (Anti-SARS-CoV-2, Placebo)
Recruiting
- COVID-19 Pneumonia
- +2 more
- Anti-SARS-CoV-2
- Placebo
-
Ciudad Autónoma De Buenos Aires, ArgentinaHospital General de Agudos Donación Francisco J. Santojanni
Sep 11, 2021
COVID-19 Trial in Mansoura (Casirivimab and Imdevimab Drug Combination, Remdesivir, Favipiravir)
Completed
- COVID-19
- Casirivimab and Imdevimab Drug Combination
- +2 more
-
Mansoura, El-dkhalia, EgyptEl-gomhoria St
Aug 13, 2022
Multiple Sclerosis Trial in Hamburg (EBBC programme, Control group programme)
Active, not recruiting
- Multiple Sclerosis
- EBBC programme
- Control group programme
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Oct 2, 2022
SARS-CoV Infection Trial in Lahore (convalescent plasma)
Active, not recruiting
- SARS-CoV Infection
- convalescent plasma
-
Lahore, Punjab, PakistanMuhammad Irfan Malik
Dec 4, 2020
COVID-19 Trial in Monterrey (Placebo, Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS))
Recruiting
- COVID-19
- Placebo
- Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS)
-
Monterrey, Nuevo Leon, MexicoHospital San José
Oct 20, 2021
Allergy;Food, Wheat Allergy, Children Trial in Hong Kong (Wheat-containing food)
Not yet recruiting
- Allergy;Food
- +2 more
- Wheat-containing food
-
Hong Kong, Hong KongDepartment of Pediatrics, 6/F, Lui Che Woo Clinical Sciences Bui
Oct 5, 2023
COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)
Completed
- COVID-19
- +2 more
- pathogen reduced SARS-CoV-2 convalescent plasma
- Placebo
-
Little Rock, Arkansas
- +25 more
Oct 6, 2022
Covid19 Trial in San José (Anti SARS-CoV-2 equine hyperimmune serum, )
Recruiting
- Covid19
- Anti SARS-CoV-2 equine hyperimmune serum
- placebo
-
San José, Costa Rica
- +3 more
May 20, 2021
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Coronavirus Disease 2019 (COVID-19) Trial in Adelaide (CSL760)
Terminated
- Coronavirus Disease 2019 (COVID-19)
- CSL760
-
Adelaide, AustraliaCMAX Clinical Research
Dec 9, 2021
Symptoms Based on Patient-reported Outcomes in Immunotherapy for
Not yet recruiting
- Esophageal Cancer
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 24, 2023
Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H
Recruiting
- Colorectal Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 18, 2023
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Atlanta, Decatur (Educational video, Interview,
Recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Educational video
- +2 more
-
Atlanta, Georgia
- +1 more
May 16, 2023
Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Recruiting
- Lung Cancer
-
Shanghai, ChinaShanghai Chest Hospital
Jul 20, 2023
High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Edegem (Dendritic cell vaccination + temozolomide-based
Recruiting
- High Grade Glioma
- Diffuse Intrinsic Pontine Glioma
- Dendritic cell vaccination + temozolomide-based chemoradiation
- Dendritic cell vaccination +- conventional next-line treatment
-
Edegem, BelgiumUnitversity Hospital Antwerp
Sep 13, 2021
Inferior Vena Caval Distensibility Index With Passive Leg
Not yet recruiting
- Spinal Anesthetics Causing Adverse Effects in Therapeutic Use
- (no location specified)
Aug 6, 2023
Minimally Residual of Esophageal Cancer 001
Recruiting
- Esophageal Carcinoma
- Minimal Residual Disease
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Jul 17, 2023
Skeletal and Dental CL I Malocclusion Moderate Crowding Trial in Baghdad (Damon Ultima bracket)
Recruiting
- Skeletal and Dental CL I Malocclusion Moderate Crowding
- Damon Ultima bracket
-
Baghdad, IraqNawar A jebory
Jul 29, 2023
Edentulous Jaw Trial in Cairo (intraoral scanner of nonsplinted scan bodies, impression material, intraoral scanner of splinted
Recruiting
- Edentulous Jaw
- intraoral scanner of nonsplinted scan bodies
- +2 more
-
Cairo, EgyptFaculty of Dentistry Ain Shams University
Mar 14, 2023
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Patient Engagement Trial (PExMS and DECIMS-Wiki, DECIMS-Wiki)
Not yet recruiting
- Multiple Sclerosis
- +3 more
- PExMS and DECIMS-Wiki
- DECIMS-Wiki
- (no location specified)
May 3, 2021
Passive Transmission of COVID-19 Antibody From Mother to Infant
Recruiting
- Passive Transmission of Maternal and Infant Antibodies
- sars-cov-2 vaccine or infection
-
Chongqing, Chongqing, ChinaChildren's hospital of chongqing medical university
May 9, 2023
COVID-19 Trial in Abu Dhabi (Human COVID-19 immunoglobulin (pH4) for intravenous injection, Placebo)
Not yet recruiting
- COVID-19
- Human COVID-19 immunoglobulin (pH4) for intravenous injection
- Placebo
-
Abu Dhabi, United Arab EmiratesAl Rahba Hospital
Dec 30, 2021
Contribution of Fractional Exhaled Nitric Oxide asPrognostic
Not yet recruiting
- Metastatic Non-small Cell Lung Cancer
- Measurement of FeNO
-
Dijon, FranceChu Dijon Bourgogne
Aug 8, 2023